Page last updated: 2024-10-22

amlodipine and Cruveilhier-Baumgarten Syndrome

amlodipine has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.

Research Excerpts

ExcerptRelevanceReference
"Treatment with amlodipine can be used to control portal hypertension in leukemic children having HCV-induced portal hypertension."2.78Treatment for hepatitis C virus-induced portal hypertension in leukemic children. ( Al-Tonbary, Y; Darwish, A; El-Ashry, R; El-Gendy, AA; Ghayaty, EA; Malek, HA, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Ashry, R1
Malek, HA1
Ghayaty, EA1
El-Gendy, AA1
Darwish, A1
Al-Tonbary, Y1

Trials

1 trial available for amlodipine and Cruveilhier-Baumgarten Syndrome

ArticleYear
Treatment for hepatitis C virus-induced portal hypertension in leukemic children.
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:2

    Topics: Administration, Oral; Amlodipine; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Ca

2013